Rankin Aubrey
Insider CIK 1818576 · RVNC President, Innovation & Tech, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-03-15 | 2022-03-17 | 1,372 | $15.79 | $21.7K | 94,091 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2021-12-03 | 2021-12-06 | 30,000 | $14.43 | $432.9K | 95,463 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-08-16 | 2021-08-17 | 9,364 | $26.34 | $246.6K | 65,463 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-08-15 | 2021-08-17 | 4,949 | $26.02 | $128.8K | 74,827 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-07-28 | 2021-07-30 | 34,332 | $30.00 | $1.03M | 321,611 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-07-28 | 2021-07-30 | 20,000 | $30.15 | $603.0K | 154,302 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-07-26 | 2021-07-28 | 55,382 | $29.72 | $1.65M | 355,943 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-06 | 2 | $28.28 | $57 | 411,325 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-03-04 | 2021-03-05 | 33,119 | $25.43 | $842.2K | 411,327 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 21,540 | — | $0 | 21,540 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-02-02 | 2021-02-04 | 11,905 | — | $0 | 79,776 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 33,119 | $25.95 | $859.4K | 444,446 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2020-12-30 | 2021-01-04 | 33,119 | $27.82 | $921.4K | 477,565 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2020-11-30 | 2020-12-02 | 33,119 | $23.85 | $789.9K | 510,684 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 33,119 | $26.15 | $866.1K | 543,803 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2020-09-28 | 2020-09-30 | 33,119 | $26.18 | $867.1K | 576,922 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-07-27 | 44,828 | $2.54 | $113.9K | 44,828 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-07-27 | 8,867 | $2.54 | $22.5K | 8,867 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-07-23 | 2020-07-27 | 610,041 | — | $0 | 610,041 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-07-23 | 2020-07-27 | 57,251 | — | $0 | 667,292 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-07-23 | 2020-09-30 | 57,251 | — | $0 | 67,871 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-07-23 | 2020-09-30 | 610,041 | — | $0 | 610,041 | SEC↗ |